PSTX - Poseida Therapeutics EPS beats by $0.05 May, 11 2021 04:41 PM Poseida Therapeutics Inc. Poseida Therapeutics (PSTX): Q1 GAAP EPS of -$0.62 beats by $0.05.Cash, cash equivalents and short-term investments of $270M.Press Release For further details see: Poseida Therapeutics EPS beats by $0.05